Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 12-2017 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 5,205 | 0 | 545,435 |
| Other current assets | 0 | 0 | 199 | 0 | -545,435 |
| TOTAL | $N/A | $N/A | $5,404 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 512 | N/A | 101,610 |
| Intangibles | 0 | 0 | 0 | 0 | 127,679 |
| Other Non-Current Assets | 0 | 0 | 532 | 0 | -229,289 |
| TOTAL | $N/A | $N/A | $1,044 | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $6,381 | $0 | $10,319,250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 141 | 0 | N/A |
| Accounts payable and accrued liabilities | 0 | 0 | 327 | 0 | 0 |
| Accrued Expenses | N/A | N/A | 1,497 | 0 | 100,947 |
| TOTAL | $N/A | $N/A | $1,965 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,824 | 0 | 245,299 |
| Other Non-Current Liabilities | 0 | 0 | 76 | 0 | -245,299 |
| TOTAL | $N/A | $N/A | $4,900 | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $6,865 | $0 | $9,103,302 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 1 | 0 | 1,972,457 |
| Retained earnings | N/A | N/A | -14,826 | 0 | -776,367 |
| Other shareholders' equity | 0 | 0 | 11,648 | 0 | 19,857 |
| TOTAL | $N/A | $N/A | $-484 | $0 | $1,215,947 |
| Total Liabilities And Equity | $0 | $0 | $6,381 | $0 | $10,319,249 |